Evolent Health (NYSE:EVH) reported second-quarter revenue of $653 million, up 31% from the first quarter, and adjusted EBITDA of $28 million, up 27% sequentially, as the company benefited from the May launch of its Highmark partnership and continued growth in its Performance Suite business.
Chief E
Healthcare solutions company Evolent Health (NYSE:EVH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 46.9% year on yea...
Healthcare solutions company Evolent Health (NYSE:EVH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 46.9% year on yea...
Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting earnings this Thursday before market hours. Here’s what to look for. Evolent Health ...
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
What Happened? Shares of healthcare solutions company Evolent Health (NYSE:EVH) fell 13% in the afternoon session after Wall Street firm Citi downgraded the ...
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare technology ...
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...
Over the last six months, Evolent Health’s shares have sunk to $3.96, producing a disappointing 5.7% loss - a stark contrast to the S&P 500’s 9.1% gain. This...
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Evolent Health (NYSE:EVH) reported first-quarter 2026 results that management said were in line with expectations, while reiterating its full-year outlook and highlighting new contract wins, early progress on major client launches and continued investment in automation.
The company reported total r
What Happened? Shares of healthcare solutions company Evolent Health (NYSE:EVH) jumped 15.8% in the afternoon session after the company reported decent first...
Healthcare solutions company Evolent Health (NYSE:EVH) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 2.6% year on year to $496.2 milli...
Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results this Thursday before the bell. Here’s what investors should know. Evolent He...
What Happened? Shares of healthcare solutions company Evolent Health (NYSE:EVH) jumped 4.1% in the afternoon session after the company reported fourth-quarte...
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Evolent Health (NYSE:...
Health insurance provider Elevance Health (NYSE:EVH) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 2.9% year on year to...
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
Health insurance provider Elevance Health (NYSE:EVH) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 2.9% year on year to $50.18 billion....
Health insurance provider Elevance Health (NYSE:EVH) will be reporting results this Wednesday morning. Here’s what to look for. Elevance Health missed analys...
